Gil Savir
Lawyers

Associate in our Capital Markets practice.
Gil advises U.S., European and Israeli issuers on various fundraising activities, including initial public offerings, other equity offerings, and public and private investment-grade and convertible debt offerings. He also advises clients ranging from early-stage privately held companies to well-known seasoned issuers on governance, SEC reporting, strategic transactions and other corporate law matters. His practice ranges across a variety of industries, including deep-tech, cybersecurity, biotech, fintech and consumer and retail.
Experience highlights
Recent Representations
- Gamida Cell $20 million follow-on offering
- LiveWire $1.77 billion merger with AEA-Bridges Impact
- MicroStrategy $500 million at-the-market offering
- Core Lab $60 million at-the-market offering
- Valuence Merger Corp. I $200 million IPO
- Screaming Eagle Acquisition $750 million IPO
- MGP Ingredients $201.25 million convertible senior notes offering
- Crown Proptech Acquisitions $808 million merger with Brivo
- Compass Digital Acquisition $200 million IPO
- Decarbonization Plus Acquisition Corporation IV $275 million IPO
- Cyteir Therapeutics $133.2 million IPO
- Molecular Partners $64 million IPO
- Nayax ILS 767 million IPO
- Decarbonization Plus Acquisition Corporation III $350 million IPO
- Paya Holdings $245 million stock offering
- Kadem Sustainable Impact $175 million IPO
Education
S.J.D., University of Michigan Law School
- Michigan Grotius Fellowship
- Phi Kappa Phi
- Scholarly Writing Award
LL.M., Taxation, University of Michigan Law School
- Phi Kappa Phi
LL.B., College of Management, Haim Striks School of Law
Professional history
- Davis Polk since 2015
Qualifications and admissions
- Israel Bar
- State of New York